Bajel Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:24 am

Competitors of Bajel Projects Ltd

All Competitor Stocks of Bajel Projects Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:45 pm

Below is a detailed analysis of the quarterly data for Bajel Projects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 607.64 Cr.. The value appears to be declining and may need further review. It has decreased from 801.42 Cr. (Mar 2025) to 607.64 Cr., marking a decrease of 193.78 Cr..
• For Expenses, as of Jun 2025, the value is 591.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 780.68 Cr. (Mar 2025) to 591.09 Cr., marking a decrease of 189.59 Cr..
• For Operating Profit, as of Jun 2025, the value is 16.55 Cr.. The value appears to be declining and may need further review. It has decreased from 20.74 Cr. (Mar 2025) to 16.55 Cr., marking a decrease of 4.19 Cr..
• For OPM %, as of Jun 2025, the value is 2.72%. The value appears strong and on an upward trend. It has increased from 2.59% (Mar 2025) to 2.72%, marking an increase of 0.13%.
• For Other Income, as of Jun 2025, the value is 8.38 Cr.. The value appears strong and on an upward trend. It has increased from 6.60 Cr. (Mar 2025) to 8.38 Cr., marking an increase of 1.78 Cr..
• For Interest, as of Jun 2025, the value is 15.87 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.95 Cr. (Mar 2025) to 15.87 Cr., marking a decrease of 1.08 Cr..
• For Depreciation, as of Jun 2025, the value is 4.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.06 Cr. (Mar 2025) to 4.61 Cr., marking an increase of 0.55 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.45 Cr.. The value appears to be declining and may need further review. It has decreased from 6.33 Cr. (Mar 2025) to 4.45 Cr., marking a decrease of 1.88 Cr..
• For Tax %, as of Jun 2025, the value is 25.62%. The value appears to be increasing, which may not be favorable. It has increased from 23.85% (Mar 2025) to 25.62%, marking an increase of 1.77%.
• For Net Profit, as of Jun 2025, the value is 3.32 Cr.. The value appears to be declining and may need further review. It has decreased from 4.82 Cr. (Mar 2025) to 3.32 Cr., marking a decrease of 1.50 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.29. The value appears to be declining and may need further review. It has decreased from 0.42 (Mar 2025) to 0.29, marking a decrease of 0.13.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:49 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bajel Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 5. It has increased from 0.37 (Mar 24) to 1.34, marking an increase of 0.97.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 5. It has increased from 0.37 (Mar 24) to 1.33, marking an increase of 0.96.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has increased from 0.87 (Mar 24) to 2.43, marking an increase of 1.56.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.63. It has increased from 49.11 (Mar 24) to 57.63, marking an increase of 8.52.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.63. It has increased from 49.11 (Mar 24) to 57.63, marking an increase of 8.52.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 224.76. It has increased from 101.42 (Mar 24) to 224.76, marking an increase of 123.34.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.80. This value is within the healthy range. It has increased from 3.10 (Mar 24) to 7.80, marking an increase of 4.70.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.70. This value is within the healthy range. It has increased from 2.59 (Mar 24) to 6.70, marking an increase of 4.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 2.07, marking an increase of 1.76.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 2. It has increased from 0.37 (Mar 24) to 1.34, marking an increase of 0.97.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 2. It has increased from 0.37 (Mar 24) to 1.34, marking an increase of 0.97.
• For PBDIT Margin (%), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 10. It has increased from 3.05 (Mar 24) to 3.47, marking an increase of 0.42.
• For PBIT Margin (%), as of Mar 25, the value is 2.98. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 2.98, marking an increase of 0.43.
• For PBT Margin (%), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 10. It has increased from 0.31 (Mar 24) to 0.92, marking an increase of 0.61.
• For Net Profit Margin (%), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 5. It has increased from 0.36 (Mar 24) to 0.59, marking an increase of 0.23.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 8. It has increased from 0.36 (Mar 24) to 0.59, marking an increase of 0.23.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 15. It has increased from 0.75 (Mar 24) to 2.32, marking an increase of 1.57.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.05. This value is within the healthy range. It has increased from 5.01 (Mar 24) to 11.05, marking an increase of 6.04.
• For Return On Assets (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from 0.31 (Mar 24) to 0.74, marking an increase of 0.43.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.18, marking an increase of 0.18.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.52. It has increased from 0.00 (Mar 24) to 1.52, marking an increase of 1.52.
• For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has decreased from 1.47 (Mar 24) to 1.13, marking a decrease of 0.34.
• For Quick Ratio (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.04, marking a decrease of 0.30.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 22.73. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 22.73, marking an increase of 22.73.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 1.69, marking a decrease of 0.24.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 3. It has decreased from 1.65 (Mar 24) to 1.29, marking a decrease of 0.36.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,743.26. It has decreased from 2,322.33 (Mar 24) to 1,743.26, marking a decrease of 579.07.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 1.99 (Mar 24) to 0.67, marking a decrease of 1.32.
• For EV / EBITDA (X), as of Mar 25, the value is 19.33. This value exceeds the healthy maximum of 15. It has decreased from 65.02 (Mar 24) to 19.33, marking a decrease of 45.69.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 2.12 (Mar 24) to 0.72, marking a decrease of 1.40.
• For Price / BV (X), as of Mar 25, the value is 2.84. This value is within the healthy range. It has decreased from 4.37 (Mar 24) to 2.84, marking a decrease of 1.53.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 2.12 (Mar 24) to 0.72, marking a decrease of 1.40.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness